Anastomosis Devices Market Report and Forecast 2025-2034
Description
The global anastomosis devices market was valued at USD 3.90 Billion in 2024, driven by increasing surgical procedures across the globe. The market is anticipated to grow at a CAGR of 5.60% during the forecast period of 2025-2034, with the values likely to reach USD 6.73 Billion by 2034.
Anastomosis Devices Market Overview
An anastomotic device is a tool that uses silk that is resorbable and sutureless to connect blood vessels or other tubular structures in the body. They are developed to be user-friendly devices, exhibit high crush resistance, and promote tissue regeneration. The increase in the number of surgical procedures, a rise in the prevalence of chronic diseases, and technological advancements in anastomosis devices are the major trends that are driving the market. Unhealthy lifestyle-related conditions such as cardiac diseases, diabetes, hypertension, obesity, and cancer are rapidly contributing to the increase in demand for these devices.
Anastomosis Devices Market Growth Drivers
Rising Number of Surgical Procedures is Likely to Elevate the Market Growth
The rising number of surgical procedures globally is a key growth driver in the market. According to the Centers for Disease Control and Prevention, 51.4 million surgeries are performed annually in the United States. Increased surgical volumes, including gastrointestinal, cardiovascular, and other complex procedures, increase the demand for advanced anastomosis devices to increase patient outcomes and reduce complications, fostering market expansion.
Anastomosis Devices Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Adoption of Minimally Invasive Technologies
The shift towards minimally invasive surgical techniques is pushing the requirement for anastomosis device innovation. The preference for devices that are smaller, more precise, and compatible with laparoscopic and robotic-assisted procedures is in line with the drive to recover faster and with minimal surgical trauma.
Growing Preference for Disposable Devices to Boost Anastomosis Devices Market Value
The demand for single-use anastomosis devices is primarily on the rise because of their potential to minimize the risk of cross-contamination and infection. This trend reflects a broader shift in healthcare toward disposable medical tools that prioritize safety, especially in sterile surgical environments. This is led by the demand for sterile and reliable devices capable of eradicating the risk of cross-contamination, especially in high-volume surgical environments.
Advancements in 3D Printing Technology to Impact Anastomosis Devices Market Size Positively
The integration of 3D printing in anastomosis devices is revolutionizing the market. With this technology, highly complex and customized structures of the devices can match the patient's anatomy efficiently. It also facilitates rapid prototyping of specialized devices at low cost.
Increasing Focus on Patient-Specific Solutions to Fuel Anastomosis Devices Market Demand
The trend toward personal treatment is influencing the design of personalized anastomosis devices specific to each patient's requirements. This is further promoting a shift toward personalized solutions that take on all unique requirements of multiple surgical disciplines, leading to better results and more adoption. These devices are specific to patients' requirements concerning unique anatomical and physiological characteristics, leading to higher surgical intervention accuracy and, by extension, better clinical results.
Anastomosis Devices Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Segmentation Based on Usage to Witness Substantial Growth
Based on usage, the market is divided into disposable and reusable. The disposable segment is expected to lead the market, owing to the availability of an array of disposable anastomotic products. These products reduce the risk of cross-contamination, surgical site infections (SSI), and other healthcare-associated infections (HAI). Another advantage of disposable anastomotic devices over reusable ones is that they reduce reprocessing costs and speed up the process, thereby, having a significant share of the market.
Anastomosis Devices Market Analysis by Region
The market is divided into various regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the market due to the high healthcare spending, the presence of well-established hospitals, and the significant presence of key players. This surge in surgical procedures is expected to increase the demand for anastomosis devices, propelling growth in the region.
Leading Players in the Anastomosis Devices Market
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Johnson & Johnson
Johnson & Johnson is an American multinational medical technologies corporation. Through its Ethicon division, the company is a major player in the market. Their Ethicon Circular Stapler features controlled tissue compression and adjustable staple height technology. It is designed to reduce anastomotic leaks, enhancing surgical outcomes with improved feedback during procedures.
Medtronic plc
Medtronic, a leading medical device company, plays a significant role in the global anastomosis devices market. They offer a wide range of surgical stapling products, including the Signia Linear Stapler with Tri-Staple Technology, TA stapler with DST Series Technology, and Purstring Staplers, used in various surgeries such as bariatric and colon surgeries.
B. Braun SE
Braun is a leading global healthcare company specializing in innovative medical products. In the anastomosis devices market, they offer a range of internal staplers, including linear cutter staplers, intraluminal staplers, and circular staplers. These products provide solutions for colorectal anastomosis and tissue selection, enhancing surgical outcomes.
Baxter International Inc.
Baxter International Inc., headquartered in Deerfield, Illinois, is a leading American healthcare company. It offers a range of products for general surgery, including hemostats, sealants, and tissue repair solutions. In the market, they address challenges like post-operative leakage and infections, with products like Floseal and Tisseel.
Other key players in the market include Intuitive Surgical, Boston Scientific Corporation, Artivion Inc., Getinge AB, Meril Life Sciences Pvt. Ltd, and Becton, Dickinson and Company.
Key Questions Answered in the Anastomosis Devices Market Report
Anastomosis Devices Market Overview
An anastomotic device is a tool that uses silk that is resorbable and sutureless to connect blood vessels or other tubular structures in the body. They are developed to be user-friendly devices, exhibit high crush resistance, and promote tissue regeneration. The increase in the number of surgical procedures, a rise in the prevalence of chronic diseases, and technological advancements in anastomosis devices are the major trends that are driving the market. Unhealthy lifestyle-related conditions such as cardiac diseases, diabetes, hypertension, obesity, and cancer are rapidly contributing to the increase in demand for these devices.
Anastomosis Devices Market Growth Drivers
Rising Number of Surgical Procedures is Likely to Elevate the Market Growth
The rising number of surgical procedures globally is a key growth driver in the market. According to the Centers for Disease Control and Prevention, 51.4 million surgeries are performed annually in the United States. Increased surgical volumes, including gastrointestinal, cardiovascular, and other complex procedures, increase the demand for advanced anastomosis devices to increase patient outcomes and reduce complications, fostering market expansion.
Anastomosis Devices Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Adoption of Minimally Invasive Technologies
The shift towards minimally invasive surgical techniques is pushing the requirement for anastomosis device innovation. The preference for devices that are smaller, more precise, and compatible with laparoscopic and robotic-assisted procedures is in line with the drive to recover faster and with minimal surgical trauma.
Growing Preference for Disposable Devices to Boost Anastomosis Devices Market Value
The demand for single-use anastomosis devices is primarily on the rise because of their potential to minimize the risk of cross-contamination and infection. This trend reflects a broader shift in healthcare toward disposable medical tools that prioritize safety, especially in sterile surgical environments. This is led by the demand for sterile and reliable devices capable of eradicating the risk of cross-contamination, especially in high-volume surgical environments.
Advancements in 3D Printing Technology to Impact Anastomosis Devices Market Size Positively
The integration of 3D printing in anastomosis devices is revolutionizing the market. With this technology, highly complex and customized structures of the devices can match the patient's anatomy efficiently. It also facilitates rapid prototyping of specialized devices at low cost.
Increasing Focus on Patient-Specific Solutions to Fuel Anastomosis Devices Market Demand
The trend toward personal treatment is influencing the design of personalized anastomosis devices specific to each patient's requirements. This is further promoting a shift toward personalized solutions that take on all unique requirements of multiple surgical disciplines, leading to better results and more adoption. These devices are specific to patients' requirements concerning unique anatomical and physiological characteristics, leading to higher surgical intervention accuracy and, by extension, better clinical results.
Anastomosis Devices Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
- Surgical Sutures
- Absorbable Sutures
- Synthetic Sutures Polyglactin 910 Sutures Poliglecaprone 25 Sutures Polydioxanone Sutures Polyglycolic Acid Sutures Other Synthetic Sutures
- Natural Sutures
- Non-Absorbable Sutures Polypropylene Sutures Nylon Sutures Stainless Steel Sutures Other Non-Absorbable Sutures
- Surgical Staplers Manual Surgical Staplers Powered Surgical Staplers
- Surgical Sealants and Adhesives Biological Surgical Sealants and Adhesives Fibrin-Based Sealants & Adhesives Collagen-Based Sealants and Adhesives Albumin-Based Sealants and Adhesives Synthetic and Semisynthetic Sealants and Adhesives PEG Hydrogel-Based Sealants and Adhesives Cyanoacrylate-Based Sealants and Adhesives Urethane-Based Sealants and Adhesives Other Synthetic and Semisynthetic Sealants and Adhesives Others
- Disposable
- Reusable
- Cardiovascular Surgery
- Gastrointestinal Surgery
- Thoracic Surgery
- Orthopedic Surgery
- Gynecological Surgery
- Others
- Hospitals and Clinics
- Ambulatory Surgery Centers
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Segmentation Based on Usage to Witness Substantial Growth
Based on usage, the market is divided into disposable and reusable. The disposable segment is expected to lead the market, owing to the availability of an array of disposable anastomotic products. These products reduce the risk of cross-contamination, surgical site infections (SSI), and other healthcare-associated infections (HAI). Another advantage of disposable anastomotic devices over reusable ones is that they reduce reprocessing costs and speed up the process, thereby, having a significant share of the market.
Anastomosis Devices Market Analysis by Region
The market is divided into various regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the market due to the high healthcare spending, the presence of well-established hospitals, and the significant presence of key players. This surge in surgical procedures is expected to increase the demand for anastomosis devices, propelling growth in the region.
Leading Players in the Anastomosis Devices Market
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Johnson & Johnson
Johnson & Johnson is an American multinational medical technologies corporation. Through its Ethicon division, the company is a major player in the market. Their Ethicon Circular Stapler features controlled tissue compression and adjustable staple height technology. It is designed to reduce anastomotic leaks, enhancing surgical outcomes with improved feedback during procedures.
Medtronic plc
Medtronic, a leading medical device company, plays a significant role in the global anastomosis devices market. They offer a wide range of surgical stapling products, including the Signia Linear Stapler with Tri-Staple Technology, TA stapler with DST Series Technology, and Purstring Staplers, used in various surgeries such as bariatric and colon surgeries.
B. Braun SE
Braun is a leading global healthcare company specializing in innovative medical products. In the anastomosis devices market, they offer a range of internal staplers, including linear cutter staplers, intraluminal staplers, and circular staplers. These products provide solutions for colorectal anastomosis and tissue selection, enhancing surgical outcomes.
Baxter International Inc.
Baxter International Inc., headquartered in Deerfield, Illinois, is a leading American healthcare company. It offers a range of products for general surgery, including hemostats, sealants, and tissue repair solutions. In the market, they address challenges like post-operative leakage and infections, with products like Floseal and Tisseel.
Other key players in the market include Intuitive Surgical, Boston Scientific Corporation, Artivion Inc., Getinge AB, Meril Life Sciences Pvt. Ltd, and Becton, Dickinson and Company.
Key Questions Answered in the Anastomosis Devices Market Report
- What was the anastomosis devices market value in 2024?
- What is the anastomosis devices market forecast outlook for 2025 2034?
- What are the regional markets covered in the EMR report?
- What is the market segmentation based on type?
- What is the market segmentation based on usage?
- What is the market breakup based on application?
- What is the market breakup based on the end user?
- What major factors aid the demand for anastomosis devices?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the major drivers, opportunities, and restraints in the market?
- What are the major trends influencing the market?
- Which regional market is expected to dominate the market share in the forecast period?
- Which country is likely to experience elevated growth during the forecast period?
- Who are the key players involved in the anastomosis devices market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Table of Contents
400 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Anastomosis Devices Market Overview
- 3.1 Global Anastomosis Devices Market Historical Value (2018-2024)
- 3.2 Global Anastomosis Devices Market Forecast Value (2025-2034)
- 4 Vendor Positioning Analysis
- 4.1 Key Vendors
- 4.2 Prospective Leaders
- 4.3 Niche Leaders
- 4.4 Disruptors
- 5 Global Anastomosis Devices Market Landscape*
- 5.1 Global Anastomosis Devices Market: Developers Landscape
- 5.1.1 Analysis by Year of Establishment
- 5.1.2 Analysis by Company Size
- 5.1.3 Analysis by Region
- 5.2 Global Anastomosis Devices Market: Product Landscape
- 5.2.1 Analysis by Type
- 5.2.2 Analysis by Usage
- 5.2.3 Analysis by Application
- 6 Global Anastomosis Devices Market Dynamics
- 6.1 Market Drivers and Constraints
- 6.2 SWOT Analysis
- 6.2.1 Strengths
- 6.2.2 Weaknesses
- 6.2.3 Opportunities
- 6.2.4 Threats
- 6.3 PESTEL Analysis
- 6.3.1 Political
- 6.3.2 Economic
- 6.3.3 Social
- 6.3.4 Technological
- 6.3.5 Legal
- 6.3.6 Environment
- 6.4 Porter’s Five Forces Model
- 6.4.1 Bargaining Power of Suppliers
- 6.4.2 Bargaining Power of Buyers
- 6.4.3 Threat of New Entrants
- 6.4.4 Threat of Substitutes
- 6.4.5 Degree of Rivalry
- 6.5 Key Demand Indicators
- 6.6 Key Price Indicators
- 6.7 Industry Events, Initiatives, and Trends
- 6.8 Value Chain Analysis
- 7 Global Anastomosis Devices Market Segmentation (218-2034)
- 7.1 Global Anastomosis Devices Market (2018-2034) by Type
- 7.1.1 Market Overview
- 7.1.2 Surgical Sutures
- 7.1.2.1 Absorbable Sutures
- 7.1.2.2 Synthetic Sutures
- 7.1.2.2.1 Polyglactin 910 Sutures
- 7.1.2.2.2 Poliglecaprone 25 Sutures
- 7.1.2.2.3 Polydioxanone Sutures
- 7.1.2.2.4 Polyglycolic Acid Sutures
- 7.1.2.2.5 Other Synthetic Sutures
- 7.1.2.3 Natural Sutures
- 7.1.2.4 Non-Absorbable Sutures
- 7.1.2.4.1 Polypropylene Sutures
- 7.1.2.4.2 Nylon Sutures
- 7.1.2.4.3 Stainless Steel Sutures
- 7.1.2.4.4 Other Non-Absorbable Sutures
- 7.1.2.5 Surgical Staplers
- 7.1.2.5.1 Manual Surgical Staplers
- 7.1.2.5.2 Powered Surgical Staplers
- 7.1.2.6 Surgical Sealants and Adhesives
- 7.1.2.6.1 Biological Surgical Sealants and Adhesives
- 7.1.2.6.2 Fibrin-Based Sealants & Adhesives
- 7.1.2.6.3 Collagen-Based Sealants and Adhesives
- 7.1.2.6.4 Albumin-Based Sealants and Adhesives
- 7.1.2.6.5 Synthetic and Semisynthetic Sealants and Adhesives
- 7.1.2.6.6 PEG Hydrogel-Based Sealants and Adhesives
- 7.1.2.6.7 Cyanoacrylate-Based Sealants and Adhesives
- 7.1.2.6.8 Urethane-Based Sealants and Adhesives
- 7.1.2.6.9 Other Synthetic and Semisynthetic Sealants and Adhesives
- 7.1.2.7 Others
- 7.2 Global Anastomosis Devices Market (2018-2034) by Usage
- 7.2.1 Market Overview
- 7.2.2 Disposable
- 7.2.3 Reusable
- 7.3 Global Anastomosis Devices Market (2018-2034) by Application
- 7.3.1 Market Overview
- 7.3.2 Cardiovascular Surgery
- 7.3.3 Gastrointestinal Surgery
- 7.3.4 Thoracic Surgery
- 7.3.5 Orthopedic Surgery
- 7.3.6 Gynecological Surgery
- 7.3.7 Others
- 7.4 Global Anastomosis Devices Market (2018-2034) by End User
- 7.4.1 Market Overview
- 7.4.2 Hospitals and Clinics
- 7.4.3 Ambulatory Surgery Centers
- 7.4.4 Others
- 7.5 Global Anastomosis Devices Market (2018-2034) by Region
- 7.5.1 Market Overview
- 7.5.2 North America
- 7.5.3 Europe
- 7.5.4 Asia Pacific
- 7.5.5 Latin America
- 7.5.6 Middle East and Africa
- 8 North America Anastomosis Devices Market (218-2034)
- 8.1 North America Anastomosis Devices Market (2018-2034) by Type
- 8.1.1 Market Overview
- 8.1.2 Surgical Sutures
- 8.1.2.1 Absorbable Sutures
- 8.1.2.2 Synthetic Sutures
- 8.1.2.2.1 Polyglactin 910 Sutures
- 8.1.2.2.2 Poliglecaprone 25 Sutures
- 8.1.2.2.3 Polydioxanone Sutures
- 8.1.2.2.4 Polyglycolic Acid Sutures
- 8.1.2.2.5 Other Synthetic Sutures
- 8.1.3 Natural Sutures
- 8.1.4 Non-Absorbable Sutures
- 8.1.4.1 Polypropylene Sutures
- 8.1.4.2 Nylon Sutures
- 8.1.4.3 Stainless Steel Sutures
- 8.1.4.4 Other Non-Absorbable Sutures
- 8.1.5 Surgical Staplers
- 8.1.5.1 Manual Surgical Staplers
- 8.1.5.2 Powered Surgical Staplers
- 8.1.6 Surgical Sealants and Adhesives
- 8.1.6.1 Biological Surgical Sealants and Adhesives
- 8.1.6.2 Fibrin-Based Sealants & Adhesives
- 8.1.6.3 Collagen-Based Sealants and Adhesives
- 8.1.6.4 Albumin-Based Sealants and Adhesives
- 8.1.6.5 Synthetic and Semisynthetic Sealants and Adhesives
- 8.1.6.6 PEG Hydrogel-Based Sealants and Adhesives
- 8.1.6.7 Cyanoacrylate-Based Sealants and Adhesives
- 8.1.6.8 Urethane-Based Sealants and Adhesives
- 8.1.6.9 Other Synthetic and Semisynthetic Sealants and Adhesives
- 8.1.7 Others
- 8.2 North America Anastomosis Devices Market (2018-2034) by Usage
- 8.2.1 Market Overview
- 8.2.2 Disposable
- 8.2.3 Reusable
- 8.3 North America Anastomosis Devices Market (2018-2034) by Application
- 8.3.1 Market Overview
- 8.3.2 Cardiovascular Surgery
- 8.3.3 Gastrointestinal Surgery
- 8.3.4 Thoracic Surgery
- 8.3.5 Orthopedic Surgery
- 8.3.6 Gynecological Surgery
- 8.3.7 Others
- 8.4 North America Anastomosis Devices Market (2018-2034) by End User
- 8.4.1 Market Overview
- 8.4.2 Hospitals and Clinics
- 8.4.3 Ambulatory Surgery Centers
- 8.4.4 Others
- 8.5 North America Anastomosis Devices Market (2018-2034) by Country
- 8.5.1 United States of America
- 8.5.1.1 United States Anastomosis Devices Market (2018-2034) by Molecule Type
- 8.5.2 Canada
- 8.5.2.1 Canada Anastomosis Devices Market (2018-2034) by Molecule Type
- 9 Europe Anastomosis Devices Market (218-2034)
- 9.1 Europe Anastomosis Devices Market (2018-2034) by Molecule Type
- 9.1.1 Market Overview
- 9.1.2 Surgical Sutures
- 9.1.2.1 Absorbable Sutures
- 9.1.2.2 Synthetic Sutures
- 9.1.2.2.1 Polyglactin 910 Sutures
- 9.1.2.2.2 Poliglecaprone 25 Sutures
- 9.1.2.2.3 Polydioxanone Sutures
- 9.1.2.2.4 Polyglycolic Acid Sutures
- 9.1.2.2.5 Other Synthetic Sutures
- 9.1.2.3 Natural Sutures
- 9.1.2.4 Non-Absorbable Sutures
- 9.1.2.4.1 Polypropylene Sutures
- 9.1.2.4.2 Nylon Sutures
- 9.1.2.4.3 Stainless Steel Sutures
- 9.1.2.4.4 Other Non-Absorbable Sutures
- 9.1.2.5 Surgical Staplers
- 9.1.2.5.1 Manual Surgical Staplers
- 9.1.2.5.2 Powered Surgical Staplers
- 9.1.2.6 Surgical Sealants and Adhesives
- 9.1.2.6.1 Biological Surgical Sealants and Adhesives
- 9.1.2.6.2 Fibrin-Based Sealants & Adhesives
- 9.1.2.6.3 Collagen-Based Sealants and Adhesives
- 9.1.2.6.4 Albumin-Based Sealants and Adhesives
- 9.1.2.6.5 Synthetic and Semisynthetic Sealants and Adhesives
- 9.1.2.6.6 PEG Hydrogel-Based Sealants and Adhesives
- 9.1.2.6.7 Cyanoacrylate-Based Sealants and Adhesives
- 9.1.2.6.8 Urethane-Based Sealants and Adhesives
- 9.1.2.6.9 Other Synthetic and Semisynthetic Sealants and Adhesives
- 9.1.2.7 Others
- 9.2 Europe Anastomosis Devices Market (2018-2034) by Usage
- 9.2.1 Market Overview
- 9.2.2 Disposable
- 9.2.3 Reusable
- 9.3 Europe Anastomosis Devices Market (2018-2034) by Application
- 9.3.1 Market Overview
- 9.3.2 Cardiovascular Surgery
- 9.3.3 Gastrointestinal Surgery
- 9.3.4 Thoracic Surgery
- 9.3.5 Orthopedic Surgery
- 9.3.6 Gynecological Surgery
- 9.3.7 Others
- 9.4 Europe Anastomosis Devices Market (2018-2034) by End User
- 9.4.1 Market Overview
- 9.4.2 Hospitals and Clinics
- 9.4.3 Ambulatory Surgery Centers
- 9.4.4 Others
- 9.5 Europe Anastomosis Devices Market (2018-2034) by Country
- 9.5.1 United Kingdom
- 9.5.1.1 United Kingdom Anastomosis Devices Market (2018-2034) by Molecule Type
- 9.5.2 Germany
- 9.5.2.1 Germany Anastomosis Devices Market (2018-2034) by Molecule Type
- 9.5.3 France
- 9.5.3.1 France Anastomosis Devices Market (2018-2034) by Molecule Type
- 9.5.4 Italy
- 9.5.4.1 Italy Anastomosis Devices Market (2018-2034) by Molecule Type
- 9.5.5 Others
- 10 Asia Pacific Anastomosis Devices Market (218-2034)
- 10.1 Asia Pacific Anastomosis Devices Market (2018-2034) by Type
- 10.1.1 Market Overview
- 10.1.2 Surgical Sutures
- 10.1.2.1 Absorbable Sutures
- 10.1.2.2 Synthetic Sutures
- 10.1.2.2.1 Polyglactin 910 Sutures
- 10.1.2.2.2 Poliglecaprone 25 Sutures
- 10.1.2.2.3 Polydioxanone Sutures
- 10.1.2.2.4 Polyglycolic Acid Sutures
- 10.1.2.2.5 Other Synthetic Sutures
- 10.1.2.3 Natural Sutures
- 10.1.2.4 Non-Absorbable Sutures
- 10.1.2.4.1 Polypropylene Sutures
- 10.1.2.4.2 Nylon Sutures
- 10.1.2.4.3 Stainless Steel Sutures
- 10.1.2.4.4 Other Non-Absorbable Sutures
- 10.1.2.5 Surgical Staplers
- 10.1.2.5.1 Manual Surgical Staplers
- 10.1.2.5.2 Powered Surgical Staplers
- 10.1.2.6 Surgical Sealants and Adhesives
- 10.1.2.6.1 Biological Surgical Sealants and Adhesives
- 10.1.2.6.2 Fibrin-Based Sealants & Adhesives
- 10.1.2.6.3 Collagen-Based Sealants and Adhesives
- 10.1.2.6.4 Albumin-Based Sealants and Adhesives
- 10.1.2.6.5 Synthetic and Semisynthetic Sealants and Adhesives
- 10.1.2.6.6 PEG Hydrogel-Based Sealants and Adhesives
- 10.1.2.6.7 Cyanoacrylate-Based Sealants and Adhesives
- 10.1.2.6.8 Urethane-Based Sealants and Adhesives
- 10.1.2.6.9 Other Synthetic and Semisynthetic Sealants and Adhesives
- 10.1.2.7 Others
- 10.2 Asia Pacific Anastomosis Devices Market (2018-2034) by Usage
- 10.2.1 Market Overview
- 10.2.2 Disposable
- 10.2.3 Reusable
- 10.3 Asia Pacific Anastomosis Devices Market (2018-2034) by Application
- 10.3.1 Market Overview
- 10.3.2 Cardiovascular Surgery
- 10.3.3 Gastrointestinal Surgery
- 10.3.4 Thoracic Surgery
- 10.3.5 Orthopedic Surgery
- 10.3.6 Gynecological Surgery
- 10.3.7 Others
- 10.4 Asia Pacific Anastomosis Devices Market (2018-2034) by End User
- 10.4.1 Market Overview
- 10.4.2 Hospitals and Clinics
- 10.4.3 Ambulatory Surgery Centers
- 10.4.4 Others
- 10.5 Asia Pacific Anastomosis Devices Market (2018-2034) by Country
- 10.5.1 China
- 10.5.1.1 China Anastomosis Devices Market (2018-2034) by Molecule Type
- 10.5.2 Japan
- 10.5.2.1 Japan Anastomosis Devices Market (2018-2034) by Molecule Type
- 10.5.3 India
- 10.5.3.1 India Anastomosis Devices Market (2018-2034) by Molecule Type
- 10.5.4 ASEAN
- 10.5.4.1 ASEAN Anastomosis Devices Market (2018-2034) by Molecule Type
- 10.5.5 Australia
- 10.5.5.1 Australia Anastomosis Devices Market (2018-2034) by Molecule Type
- 10.5.6 Others
- 11 Latin America Anastomosis Devices Market (218-2034)
- 11.1 Latin America Anastomosis Devices Market (2018-2034) by Type
- 11.1.1 Market Overview
- 11.1.2 Surgical Sutures
- 11.1.2.1 Absorbable Sutures
- 11.1.2.2 Synthetic Sutures
- 11.1.2.2.1 Polyglactin 910 Sutures
- 11.1.2.2.2 Poliglecaprone 25 Sutures
- 11.1.2.2.3 Polydioxanone Sutures
- 11.1.2.2.4 Polyglycolic Acid Sutures
- 11.1.2.2.5 Other Synthetic Sutures
- 11.1.2.3 Natural Sutures
- 11.1.2.4 Non-Absorbable Sutures
- 11.1.2.4.1 Polypropylene Sutures
- 11.1.2.4.2 Nylon Sutures
- 11.1.2.4.3 Stainless Steel Sutures
- 11.1.2.4.4 Other Non-Absorbable Sutures
- 11.1.2.5 Surgical Staplers
- 11.1.2.5.1 Manual Surgical Staplers
- 11.1.2.5.2 Powered Surgical Staplers
- 11.1.2.6 Surgical Sealants and Adhesives
- 11.1.2.6.1 Biological Surgical Sealants and Adhesives
- 11.1.2.6.2 Fibrin-Based Sealants & Adhesives
- 11.1.2.6.3 Collagen-Based Sealants and Adhesives
- 11.1.2.6.4 Albumin-Based Sealants and Adhesives
- 11.1.2.6.5 Synthetic and Semisynthetic Sealants and Adhesives
- 11.1.2.6.6 PEG Hydrogel-Based Sealants and Adhesives
- 11.1.2.6.7 Cyanoacrylate-Based Sealants and Adhesives
- 11.1.2.6.8 Urethane-Based Sealants and Adhesives
- 11.1.2.6.9 Other Synthetic and Semisynthetic Sealants and Adhesives
- 11.1.2.7 Others
- 11.2 Latin America Anastomosis Devices Market (2018-2034) by Usage
- 11.2.1 Market Overview
- 11.2.2 Disposable
- 11.2.3 Reusable
- 11.3 Latin America Anastomosis Devices Market (2018-2034) by Application
- 11.3.1 Market Overview
- 11.3.2 Cardiovascular Surgery
- 11.3.3 Gastrointestinal Surgery
- 11.3.4 Thoracic Surgery
- 11.3.5 Orthopedic Surgery
- 11.3.6 Gynecological Surgery
- 11.3.7 Others
- 11.4 Latin America Anastomosis Devices Market (2018-2034) by End User
- 11.4.1 Market Overview
- 11.4.2 Hospitals and Clinics
- 11.4.3 Ambulatory Surgery Centers
- 11.4.4 Others
- 11.5 Latin America Anastomosis Devices Market (2018-2034) by Country
- 11.5.1 Brazil
- 11.5.1.1 Brazil Anastomosis Devices Market (2018-2034) by Molecule Type
- 11.5.2 Argentina
- 11.5.2.1 Argentina Anastomosis Devices Market (2018-2034) by Molecule Type
- 11.5.3 Mexico
- 11.5.3.1 Mexico Anastomosis Devices Market (2018-2034) by Molecule Type
- 11.5.4 Others
- 12 Middle East and Africa Anastomosis Devices Market (218-2034)
- 12.1 Middle East and Africa Anastomosis Devices Market (2018-2034) by Type
- 12.1.1 Market Overview
- 12.1.2 Surgical Sutures
- 12.1.2.1 Absorbable Sutures
- 12.1.2.2 Synthetic Sutures
- 12.1.2.2.1 Polyglactin 910 Sutures
- 12.1.2.2.2 Poliglecaprone 25 Sutures
- 12.1.2.2.3 Polydioxanone Sutures
- 12.1.2.2.4 Polyglycolic Acid Sutures
- 12.1.2.2.5 Other Synthetic Sutures
- 12.1.2.3 Natural Sutures
- 12.1.2.4 Non-Absorbable Sutures
- 12.1.2.4.1 Polypropylene Sutures
- 12.1.2.4.2 Nylon Sutures
- 12.1.2.4.3 Stainless Steel Sutures
- 12.1.2.4.4 Other Non-Absorbable Sutures
- 12.1.2.5 Surgical Staplers
- 12.1.2.5.1 Manual Surgical Staplers
- 12.1.2.5.2 Powered Surgical Staplers
- 12.1.2.6 Surgical Sealants and Adhesives
- 12.1.2.6.1 Biological Surgical Sealants and Adhesives
- 12.1.2.6.2 Fibrin-Based Sealants & Adhesives
- 12.1.2.6.3 Collagen-Based Sealants and Adhesives
- 12.1.2.6.4 Albumin-Based Sealants and Adhesives
- 12.1.2.6.5 Synthetic and Semisynthetic Sealants and Adhesives
- 12.1.2.6.6 PEG Hydrogel-Based Sealants and Adhesives
- 12.1.2.6.7 Cyanoacrylate-Based Sealants and Adhesives
- 12.1.2.6.8 Urethane-Based Sealants and Adhesives
- 12.1.2.6.9 Other Synthetic and Semisynthetic Sealants and Adhesives
- 12.1.2.7 Others
- 12.2 Middle East and Africa Anastomosis Devices Market (2018-2034) by Usage
- 12.2.1 Market Overview
- 12.2.2 Disposable
- 12.2.3 Reusable
- 12.3 Middle East and Africa Anastomosis Devices Market (2018-2034) by Application
- 12.3.1 Market Overview
- 12.3.2 Cardiovascular Surgery
- 12.3.3 Gastrointestinal Surgery
- 12.3.4 Thoracic Surgery
- 12.3.5 Orthopedic Surgery
- 12.3.6 Gynecological Surgery
- 12.3.7 Others
- 12.4 Middle East and Africa Anastomosis Devices Market (2018-2034) by End User
- 12.4.1 Market Overview
- 12.4.2 Hospitals and Clinics
- 12.4.3 Ambulatory Surgery Centers
- 12.4.4 Others
- 12.5 Middle East and Africa Anastomosis Devices Market (2018-2034) by Country
- 12.5.1 Saudi Arabia
- 12.5.1.1 Saudi Arabia Anastomosis Devices Market (2018-2034) by Molecule Type
- 12.5.2 United Arab Emirates
- 12.5.2.1 United Arab Emirates Anastomosis Devices Market (2018-2034) by Molecule Type
- 12.5.3 Nigeria
- 12.5.3.1 Nigeria Anastomosis Devices Market (2018-2034) by Molecule Type
- 12.5.4 South Africa
- 12.5.4.1 South Africa Anastomosis Devices Market (2018-2034) by Molecule Type
- 12.5.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication Year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 14 Grants Analysis
- 14.1 Analysis by Year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Application
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by NIH Departments
- 14.7 Analysis by Recipient Organization
- 15 Funding and Investment Analysis
- 15.1 Analysis by Funding Instances
- 15.2 Analysis by Drug Class of Funding
- 15.3 Analysis by Funding Amount
- 15.4 Analysis by Leading Players
- 15.5 Analysis by Leading Investors
- 15.6 Analysis by Geography
- 16 Strategic Initiatives
- 16.1 Analysis by Partnership Instances
- 16.2 Analysis by Drug Class of Partnership
- 16.3 Analysis by Leading Players
- 16.4 Analysis by Geography
- 17 Supplier Landscape
- 17.1 Market Share Analysis, By Region (Top 5 Companies)
- 17.1.1 Market Share Analysis: Global
- 17.1.2 Market Share Analysis: North America
- 17.1.3 Market Share Analysis: Europe
- 17.1.4 Market Share Analysis: Asia Pacific
- 17.1.5 Market Share Analysis: Others
- 17.2 Johnson & Johnson
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Company News and Development
- 17.2.5 Certifications
- 17.3 Medtronic plc
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Company News and Development
- 17.3.5 Certifications
- 17.4 B. Braun SE
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Company News and Development
- 17.4.5 Certifications
- 17.5 Intuitive Surgical
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Company News and Development
- 17.5.5 Certifications
- 17.6 Boston Scientific Corporation
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Company News and Development
- 17.6.5 Certifications
- 17.7 Artivion Inc.
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Company News and Development
- 17.7.5 Certifications
- 17.8 Baxter International Inc.
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Company News and Development
- 17.8.5 Certifications
- 17.9 Getinge AB
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Company News and Development
- 17.9.5 Certifications
- 17.10 Meril Life Sciences Pvt. Ltd
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Company News and Development
- 17.10.5 Certifications
- 17.11 Becton, Dickinson and Company
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Company News and Development
- 17.11.5 Certifications
- 18 Global Anastomosis Devices Market – Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
